Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Furthermore, the normalized activated protein C sensitivity ratio of 80% of the users of third-generation preparations fell within the 5th to 95th percentile of the normalized activated protein C sensitivity ratio of female carriers of factor V Leiden, a mutation that is associated with hereditary resistance to activated protein C and with an increased risk of venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Furthermore, the normalized activated protein C sensitivity ratio of 80% of the users of third-generation preparations fell within the 5th to 95th percentile of the normalized activated protein C sensitivity ratio of female carriers of factor V Leiden, a mutation that is associated with hereditary resistance to activated protein C and with an increased risk of venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Furthermore, the normalized activated protein C sensitivity ratio of 80% of the users of third-generation preparations fell within the 5th to 95th percentile of the normalized activated protein C sensitivity ratio of female carriers of factor V Leiden, a mutation that is associated with hereditary resistance to activated protein C and with an increased risk of venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Furthermore, the normalized activated protein C sensitivity ratio of 80% of the users of third-generation preparations fell within the 5th to 95th percentile of the normalized activated protein C sensitivity ratio of female carriers of factor V Leiden, a mutation that is associated with hereditary resistance to activated protein C and with an increased risk of venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP254969.RADPoMb0B_wcwyIuCivs94C7mS8WuTr0QNMDCmf4HApFU130_assertion description "[Furthermore, the normalized activated protein C sensitivity ratio of 80% of the users of third-generation preparations fell within the 5th to 95th percentile of the normalized activated protein C sensitivity ratio of female carriers of factor V Leiden, a mutation that is associated with hereditary resistance to activated protein C and with an increased risk of venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254969.RADPoMb0B_wcwyIuCivs94C7mS8WuTr0QNMDCmf4HApFU130_provenance.
• NP254973.RAQ1ql9NVldVzf0kgY9qm8kKnN-KuL0vPwZPKYH6ta3g4130_assertion description "[Furthermore, the normalized activated protein C sensitivity ratio of 80% of the users of third-generation preparations fell within the 5th to 95th percentile of the normalized activated protein C sensitivity ratio of female carriers of factor V Leiden, a mutation that is associated with hereditary resistance to activated protein C and with an increased risk of venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254973.RAQ1ql9NVldVzf0kgY9qm8kKnN-KuL0vPwZPKYH6ta3g4130_provenance.
• NP254970.RAhfjKmQS7rvB5Uhj31YMYCyHqK3rV098e5cmpnHCDBKs130_assertion description "[Furthermore, the normalized activated protein C sensitivity ratio of 80% of the users of third-generation preparations fell within the 5th to 95th percentile of the normalized activated protein C sensitivity ratio of female carriers of factor V Leiden, a mutation that is associated with hereditary resistance to activated protein C and with an increased risk of venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254970.RAhfjKmQS7rvB5Uhj31YMYCyHqK3rV098e5cmpnHCDBKs130_provenance.
• NP254974.RAsnHbHlZhvLXbUwKSpoiniDU22ZGVXLHwMdsb2fXl_vY130_assertion description "[Furthermore, the normalized activated protein C sensitivity ratio of 80% of the users of third-generation preparations fell within the 5th to 95th percentile of the normalized activated protein C sensitivity ratio of female carriers of factor V Leiden, a mutation that is associated with hereditary resistance to activated protein C and with an increased risk of venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254974.RAsnHbHlZhvLXbUwKSpoiniDU22ZGVXLHwMdsb2fXl_vY130_provenance.
• NP254965.RAPTEVs0MYwueqwTCP6kOVvZsNME6DMag7AMYufPTVOiM130_assertion description "[Furthermore, the normalized activated protein C sensitivity ratio of 80% of the users of third-generation preparations fell within the 5th to 95th percentile of the normalized activated protein C sensitivity ratio of female carriers of factor V Leiden, a mutation that is associated with hereditary resistance to activated protein C and with an increased risk of venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254965.RAPTEVs0MYwueqwTCP6kOVvZsNME6DMag7AMYufPTVOiM130_provenance.
• NP254966.RAxEik3sR7ST3lSV5nqErXAoH69yOtCfjY6QzPo6tm8TA130_assertion description "[Furthermore, the normalized activated protein C sensitivity ratio of 80% of the users of third-generation preparations fell within the 5th to 95th percentile of the normalized activated protein C sensitivity ratio of female carriers of factor V Leiden, a mutation that is associated with hereditary resistance to activated protein C and with an increased risk of venous thromboembolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254966.RAxEik3sR7ST3lSV5nqErXAoH69yOtCfjY6QzPo6tm8TA130_provenance.